OpenAI just signed a multibillion-dollar deal with Amazon’s cloud business for access to AI chips. Amazon Web Services is the ...

Now, it’s worth noting Stock Advisor's total average return is 1,072% — a market-crushing outperformance compared to 194% for ...

Amazon says the constraint right now is power, not chips; it’s giving plenty of the latter to OpenAI. Then, Amazon solves ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...

Shopping agents may one day pose a significant threat to Amazon’s lucrative advertising business The e-commerce giant is ...

The deal underscores the AI industry’s insatiable appetite for computing power, pushing Amazon shares to an all-time high.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...

The new Bridgewater Retail Park store launch on November 11 creates 30 jobs, offers multi-buy bargains, and rewards early ...

Fears that stocks are becoming overvalued led to a broader selloff on Tuesday, especially among the tech-centric Nasdaq.

Naked Wines is offering £80 off a 15-bottle mixed case from independent winemakers, plus a free magnum of Australian Shiraz, ...